false
Catalog
LAAO-0221 - Inclusion Criteria | Trial Study Popul ...
0221 - Inclusion Criteria | Trial Study Population ...
0221 - Inclusion Criteria | Trial Study Populations
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, the LAO Registry presents the case of Mrs. Jackson, who undergoes an LAA Occlusion Procedure as part of the Option Trial. The video discusses the Registry's Submission Population Inclusion Criteria, specifically focusing on patients participating in trials or studies. According to the updated criteria, patients enrolled in the Option, Champion, AF, and ASAP2 trials will be excluded from the registry. However, patients who have a Watchman FLX implanted and are not participating in the Option Trial will be included in the registry if the procedure took place on or after July 21, 2020. Patients in the Amulet and Wavecrest Trials who are randomized to the Watchman arm and have a Watchman device implanted will also be included, while those with Amulet or Wavecrest devices will not be included. Lariat procedures in the AMAZE trial are also excluded. Viewers are encouraged to refer to the updated Registry Submission Population Inclusion Criteria document for further details. No credits given for the video.
Keywords
LAO Registry
Mrs. Jackson
LAA Occlusion Procedure
Option Trial
Registry Submission Population Inclusion Criteria
×
Please select your language
1
English